drugset / Trial / NCT03083496

Clinical Evaluation of Different Potassium Oxalate Concentrations in Dentin Hypersensitivity Treatment

NCT03083496

RandomizedParallel-groupTriple-blindTreatment

Summary

This study aims to evaluate the longevity and efficacy of two products potassium oxalate-basedin two concentrations, 10% and 5%, by triple randomized blind clinical trial (split-mouth) . The desensitization approach (single agent) and the long-term effectiveness (baseline, 1 week, 2 weeks, 3 weeks). Data will be collected, tabulated and submitted to statistical analysis.

Timeline

Start
2017-03-14
Primary completion
2017-06
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Potassium Oxalate Unknown 5 %
Comparator Potassium Oxalate Unknown 10 %

Indications